Form 4: Johnson & Johnson Executive VP, General Counsel, Elizabeth Forminard, Reports Stock Option and Restricted Share Unit Awards

Elizabeth Forminard, Executive VP and General Counsel of Johnson & Johnson, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

Summary

• Elizabeth Forminard, Executive VP and General Counsel of Johnson & Johnson, filed a Form 4 on February 19, 2025.
• The filing reports the acquisition of employee stock options and restricted share units (RSUs) awarded under Johnson & Johnson's Long-Term Incentive Plan on February 15, 2025.
• Forminard acquired 51,688 employee stock options with an exercise price of $156.15, vesting in three equal annual installments beginning on February 15, 2026, and expiring on February 15, 2035.
• She also acquired 3,189 restricted share units (RSUs), vesting in three equal annual installments beginning on February 15, 2026, and converting into common stock on a one-for-one basis upon vesting.
• Following the reported transactions, Forminard beneficially owns 51,688 employee stock options and 3,189 restricted share units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice and reflects a commitment to aligning executive interests with shareholder value. There are no explicitly negative aspects presented in the document.

Positives

• The granting of stock options and RSUs to a key executive like the General Counsel suggests the company's commitment to aligning management's interests with those of shareholders.
• The vesting schedule of the awards (three equal annual installments) encourages long-term performance and retention of the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options and RSUs.

Industry Context

Stock option and RSU grants are common compensation practices for executives in publicly traded companies like Johnson & Johnson, aligning their interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

• Granting stock options and restricted stock units is a standard practice among large, publicly traded companies like Johnson & Johnson to incentivize and retain key executives.
• Companies such as Pfizer (PFE), Merck (MRK), and AbbVie (ABBV) also utilize similar long-term incentive plans for their executive teams.
• The vesting schedules, typically three to four years, are also in line with industry norms to ensure sustained commitment and performance.

Stakeholder Impact

• Shareholders: The granting of stock options and RSUs aims to align executive performance with shareholder value.
• Employees: The Long-Term Incentive Plan can motivate employees through potential future equity ownership.
• Executive: The executive is incentivized to improve company performance over the long term to maximize the value of the stock options and RSUs.

Key Dates

Keywords

Form 4, Johnson & Johnson, JNJ, Elizabeth Forminard, Executive VP, General Counsel, Stock Options, Restricted Share Units, Long-Term Incentive Plan, Beneficial Ownership, Vesting